Imagine you have spent many years trying to develop new techniques that could one day cure cardiac disease, cancer or Parkinson's disease, you finally arrive at the point where it appears logical to move up from mice to human cell cultures, only to find yourself accused of 'cannibalism' by an archbishop preaching one of the year's most important masses at Cologne cathedral. Unbelievable? It happened in Germany in early June, when the discussion about the possible use of embryonic stem (ES) cells boiled over. The potential benefits of the technique, which had been obvious since human ES cells were first reported in November 1998, suddenly vanished behind a barrage of criticism.
According to the embryo protection law (Embryonenschutzgesetz), researchers in Germany are not allowed to produce stem cells from 'spare' embryos left over after IVF treatment, as this would require a six-day-old embryo to be destroyed. Although this blastocyst is only a ball of just over 100 perfectly undifferentiated cells, which in the womb may or may not succeed in establishing a pregnancy, and could be legally aborted for another eleven weeks if it does, the law sees it as alive from the moment of fertilization. (Strangely, it is perfectly legal to throw that very same embryo in the dustbin, where it will die just as certainly.) There is a loophole, however, as current legislation cannot stop German researchers from ordering stem cells out of the cell lines produced in the US, Australia, and Israel, and using them for their research in Germany. This is what the heart specialist Wolfgang-Michael Franz was hoping to do last year at the University of Lübeck. Having demonstrated the production of functional heart cells from mouse ES cells, he wanted to apply his method to human cells and ordered ES cells from the company WiCell in Madison, Wisconsin.
Stunned scientists have shelved their plans awaiting political decisions from funding agencies and the government By the time the material arrived at Lübeck in May this year, Franz had moved to a hospital at Munich. The cells were put in the freezer and very nearly forgotten, until a camera team from the most influential TV news programme found them at the beginning of July. In the face of a heated public debate which has culminated in criticism placing stem cell researchers in the uncomfortable neighbourhood of Drs Frankenstein and Mengele, stunned scientists have shelved their plans awaiting political decisions from funding organizations and the government. One part of the problem is the lack of an established advisory body that could help politicians on such tricky questions. A national ethics board has only been established a few months ago, but of its members, only the geneticist Ernst-Ludwig Winnacker, president of the major funding agency DFG, has spoken out on the ES cell debate. There is no national academy of science comparable to the Royal Society or the French and US academies. True to the federal tradition of German administration, there are regional scientific academies, whose leaders have so far failed to come up with a consensus on how a unified body at the national level could improve the communication between science and politics. Individual voices from various parts of the life sciencesclearly fearing that a more general backlash against biomedical research would affect areas so far exempt from criticism -have called for a voluntary moratorium on the use of ES cells until a legal framework has been created. Some also fear that maverick researchers would try to use stem cell research as a gateway to cloning humans. However, an outright ban on the import has been declared both unacceptable and impossible to police.
Thus, all eyes are turning towards the Berlin parliament (Bundestag), which is expected to make a decision on the use of imported stem cells this autumn. The political problem here is that the issue splits both the red-green coalition government and the conservative opposition. The conservative parties CDU and CSU represent some very strict catholic parts of the population who would follow the above quoted archbishop in condemning any research that has anything to do with human embryos.
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However, these parties also include people who blindly believe the promises of any new technology and are happy to impose it against strong opposition. The liberal democrats (FDP) are mostly in favour of allowing research with ES cells and want to speed up the parliamentary process, the Green party is mostly against giving researchers more freedom, but has also turned down the CDU's call for a ban on imports. Chancellor Gerhard Schröder's social democrats are split between the positions of research minister Edelgard Bulmahn (for stem cell research) and justice minister Herta Däubler-Gmelin (against). Hence, only the most ardent proponents of both extremes are keen on this debate, while most party officials are afraid to see the rifts within their own party exposed. When the issue comes up for parliamentary debate in autumn, the final outcome will be open.
Considering that the spectre of the Nazi experiments on human subjects and their views on selection of the fittest is one of the main ethical crunch points in the German debate (particularly for skeptics in the red-green coalition), it appears paradoxical that the country most entitled to such worries, Israel, has thrown them overboard and embraces stem cell research more enthusiastically than almost any other nation.
Leading voices of science ethics in Israel are in agreement that, according to Judaism, an early phase human embryo does not merit more protection than a sperm or egg cell. One wouldn't want to waste a potential human being, but it is acceptable to use it for a good cause such as health research or reproduction. Such religiously based statements on scientific issues dominate both public opinion and political decisions in areas such as in reproduction medicine, surrogate motherhood, or cloning. Surprisingly, the resulting policies tend to be more permissive of the application of new biomedical techniques than those in countries deriving their ethical framework from Christianity.
Thus, the Israeli Joseph Itskovitz-Eldor was inhibited neither by religious nor by political concerns when he became involved in the creation of both the very first human ES stem cell line -which was reported in Science in November 1998 and is now in the care of the company Geron at Menlo Park, California -and later of another cell line at his own workplace at the Technion at Haifa. The Jerusalem Post quotes him as saying that he expects that the ES cells will make human tissue repair possible within three to five years. Therefore, he is keen to spread the use of stem cells for biomedical research by cooperation with carefully selected laboratories in other countries, and he is said to be willing to collaborate with German researchers such as the neuropathologist Oliver Brüstle from Bonn University, who recently traveled to Haifa in the company of the chief of his regional government, Wolfgang Clement, to discuss such possibilities.
Before they can set to work, however, some persuasion will be required to change the political tide in Germany. Currently, Brüstle is under police protection around the clock, following death threats made against him. Many other researchers whose work could involve stem cells in the future have not dared to speak out. Maybe Itskovitz-Eldor should consider a return visit to Bonn to help his colleague explain to the German public that ES cell research is about repairing damaged tissue, not about eating children.
Michael Gross is a science writer based at the Oxford Centre for Molecular Sciences. He can be contacted through his web page at www.michaelgross.co.uk.
Cells of contention:
An early human embryo, which can provide a source of stem cells, fits easily on the tip of a needle. But the problems raised by such a potential are far from microscopic. Yorgos Nikas, Science Photo Library.
